Stay updated on Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial
Sign up to get notified when there's something new on the Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial page.

Latest updates to the Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedAdded Naples, Italy and removed Napoli, Italy in the Italy locations to reflect the current site listings with English city names.SummaryDifference0.0%

- Check17 days agoChange DetectedAdded Hepatocellular carcinoma and a new Genetic and Rare Diseases Information Center resource; updated the page revision to v3.5.0 (replacing v3.4.3).SummaryDifference0.1%

- Check24 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded Revision: v3.4.2. Removed the previous funding/operating status notice and Revision: v3.4.1 text.SummaryDifference0.2%

- Check60 days agoChange DetectedA system-wide notice about government funding and operations is now shown, and the page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check67 days agoChange DetectedA glossary toggle was added; QC-related labels were standardized (Last Update Submitted that Met QC Criteria), and the revision version was updated to v3.4.0, while the No FEAR Act data label was updated from lowercase to uppercase.SummaryDifference0.1%

Stay in the know with updates to Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial page.